BRINTELLIX

Welcome to the Brand page for “BRINTELLIX”, which is offered here for Vaccines; pharmaceutical preparations for treatment and prevention of central nervous system diseases and disorders; pharmaceutical preparations acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations for the treatment and prevention of dementia, alzheimer's disease and disorder, dizziness, seizures, strokes, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety disorder, apathy disorder, epilepsy, lennox-gastaut syndrome (lgs), sclerosis, porphyria, huntington's disorder and disease, insomnia, parkinson's disorder and disease, balance disorders, movement disorders and diseases, dyskinesia, motor disorder, tremors, schizophrenia, bipolar disorder and disease, mania, attention deficit hyperactivity disorder, post traumatic stress disorder, agitated major depressive disorder, intermittent explosive disorder, autism, melancholic depression, tourette's syndrome, progressive supranuclear palsy (psp), restless leg syndrome, akathisia, chronic fatigue syndrome, somnolence, nausea, cancer, headache, migraine, pain, alcoholism and chemical dependency; diagnostic agents, preparations and substances for medical purposes;.

Its status is currently believed to be active. Its class is unavailable. “BRINTELLIX” is believed to be currently owned by “H. Lundbeck A/S”.